Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Inflammatory Bowel Diseases

Free Subscription Articles published in Aliment Pharmacol Ther Retrieve available abstracts of 164 articles: HTML format Text format

Single Articles

February 2012
1. JAKOBSEN C , Bartek J Jr, Wewer V, Vind I, et al
   Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease: authors' reply.
   Aliment Pharmacol Ther. 2012;35:392-3.
   PubMed     Text format     Related articles   
   
   
   
   
2. HENDERSON P , Wilson DC, Satsangi J
   Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease.
   Aliment Pharmacol Ther. 2012;35:391-2.
   PubMed     Text format     Related articles   
   
   
   
   
3. CAMERINI R
   Can we treat ulcerative colitis with nutritional supplements? author's reply.
   Aliment Pharmacol Ther. 2012;35:486-7.
   PubMed     Text format     Related articles   
   
   
   
   
4. ANNUNZIATA ML , Hanauer S
   Can we treat ulcerative colitis with nutritional supplements?
   Aliment Pharmacol Ther. 2012;35:485.
   PubMed     Text format     Related articles   
   
   
   
   January 2012
5. CHATU S , Subramanian V, Pollok RC
   Meta-analysis: diagnostic medical radiation exposure in inflammatory bowel disease.
   Aliment Pharmacol Ther. 2012 Jan 13. doi: 10.1111/j.1365-2036.2011.04975.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. ROSTHOLDER E , Ahmed A, Cheifetz AS, Moss AC, et al
   Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis.
   Aliment Pharmacol Ther. 2012 Jan 13. doi: 10.1111/j.1365-2036.2011.04986.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. SONNENBERG A , Genta RM
   Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease.
   Aliment Pharmacol Ther. 2012 Jan 5. doi: 10.1111/j.1365-2036.2011.04969.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. HABAL FM , Huang VW
   Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.
   Aliment Pharmacol Ther. 2012 Jan 5. doi: 10.1111/j.1365-2036.2011.04967.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. BACCHIERI A , Camerini R
   Is propionyl-L-carnitine therapy effective in ulcerative colitis? authors' reply.
   Aliment Pharmacol Ther. 2012;35:316-7.
   PubMed     Text format     Related articles   
   
   
   
   
10. TURNER LV , Hamlin PJ
    Is propionyl-l-carnitine therapy effective in ulcerative colitis?
    Aliment Pharmacol Ther. 2012;35:315-6.
    PubMed     Text format     Related articles   
    
    
    
    
11. BROOKS AJ , Lobo AJ
    Are mesalazine granules superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis?
    Aliment Pharmacol Ther. 2012;35:193-4.
    PubMed     Text format     Related articles   
    
    
    
    December 2011
12. WEIZMAN AV , Ahn E, Thanabalan R, Leung W, et al
    Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 Dec 18. doi: 10.1111/j.1365-2036.2011.04956.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. OLIVA S , Di Nardo G, Ferrari F, Mallardo S, et al
    Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis.
    Aliment Pharmacol Ther. 2011 Dec 8. doi: 10.1111/j.1365-2036.2011.04939.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. CHAPARRO M , Burgueno P, Iglesias E, Panes J, et al
    Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Aliment Pharmacol Ther. 2011 Dec 5. doi: 10.1111/j.1365-2036.2011.04934.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. CHAN SS , Hart AR
    Aspirin use and development of inflammatory bowel disease: confounding or causation? authors' reply.
    Aliment Pharmacol Ther. 2011;34.
    PubMed     Text format     Related articles   
    
    
    
    
16. YI F , Xia B
    Aspirin use and development of inflammatory bowel disease: confounding or causation?
    Aliment Pharmacol Ther. 2011;34.
    PubMed     Text format     Related articles   
    
    
    
    November 2011
17. BAGER P , Befrits R, Wikman O, Lindgren S, et al
    Fatigue in out-patients with inflammatory bowel disease is common and multifactorial.
    Aliment Pharmacol Ther. 2011 Nov 7. doi: 10.1111/j.1365-2036.2011.04914.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CHOUCHANA L , Narjoz C, Beaune P, Loriot MA, et al
    Review article: benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 Nov 2. doi: 10.1111/j.1365-2036.2011.04905.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. GREEN J , Matthews S, Campbell A
    Lactose intolerance in inflammatory bowel disease/Association of lactose sensitivity with inflammatory bowel disease - demonstrated by analysis of genetic polymorphism, breath tests and symptoms: authors' reply.
    Aliment Pharmacol Ther. 2011;34:1142-4.
    PubMed     Text format     Related articles   
    
    
    
    
20. BARRETT JS , Muir JG
    Association of lactose sensitivity with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011;34:1141-2.
    PubMed     Text format     Related articles   
    
    
    
    
21. GARG M , Gibson PR
    Lactose intolerance in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011;34:1140-1.
    PubMed     Text format     Related articles   
    
    
    
    
22. GONZALEZ-LAMA Y , Gisbert JP
    Thiopurine metabolites and TPMT activity measurement in inflammatory bowel disease: authors' reply.
    Aliment Pharmacol Ther. 2011;34:1139-40.
    PubMed     Text format     Related articles   
    
    
    
    
23. LOUIS E
    Thiopurine metabolites and TPMT activity measurement in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011;34:1138-9.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
24. TINSLEY A , Macklin EA, Korzenik JR, Sands BE, et al
    Validation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) in Patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 Oct 17. doi: 10.1111/j.1365-2036.2011.04871.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. JAKOBSEN C , Bartek J Jr, Wewer V, Vind I, et al
    Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease - a population-based study.
    Aliment Pharmacol Ther. 2011 Oct 9. doi: 10.1111/j.1365-2036.2011.04857.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. MOERIKE M
    Inaccuracies concerning Salofalk granules.
    Aliment Pharmacol Ther. 2011;34:824.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
27. CULLEN G , Kroshinsky D, Cheifetz AS, Korzenik JR, et al
    Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.
    Aliment Pharmacol Ther. 2011 Sep 29. doi: 10.1111/j.1365-2036.2011.04866.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. MIKHAILOVA TL , Sishkova E, Poniewierka E, Zhidkov KP, et al
    Randomised clinical trial: the efficacy and safety of propionyl-l-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.
    Aliment Pharmacol Ther. 2011 Sep 19. doi: 10.1111/j.1365-2036.2011.04844.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. LEIFELD L , Pfutzer R, Morgenstern J, Gibson PR, et al
    Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis.
    Aliment Pharmacol Ther. 2011 Sep 19. doi: 10.1111/j.1365-2036.2011.04840.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. FUKUCHI T , Nakase H, Ito D, Yamashita H, et al
    Rapid induction of mucosal healing by intensive granulocyte and monocyte adsorptive aphaeresis in active ulcerative colitis patients without concomitant corticosteroid therapy.
    Aliment Pharmacol Ther. 2011;34:583-5.
    PubMed     Text format     Related articles   
    
    
    
    
31. DESHPANDE AR , Strobel S
    Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.
    Aliment Pharmacol Ther. 2011;34:586.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
32. SANDBORN WJ , Hanauer S, Lichtenstein GR, Safdi M, et al
    Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis - additional results from two controlled studies.
    Aliment Pharmacol Ther. 2011 Aug 16. doi: 10.1111/j.1365-2036.2011.04800.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. AOMATSU T , Imaeda H, Matsumoto K, Kimura E, et al
    Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 Aug 16. doi: 10.1111/j.1365-2036.2011.04805.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. EADALA P , Matthews SB, Waud JP, Green JT, et al
    Association of lactose sensitivity with inflammatory bowel disease - demonstrated by analysis of genetic polymorphism, breath gases and symptoms.
    Aliment Pharmacol Ther. 2011 Aug 4. doi: 10.1111/j.1365-2036.2011.04799.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. BORTOLI A , Pedersen N, Duricova D, D Inca R, et al
    Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006.
    Aliment Pharmacol Ther. 2011 Aug 4. doi: 10.1111/j.1365-2036.2011.04794.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. POLLOK RC , Saxena S, Jen MH
    Increased health burden associated with Clostridium difficile diarrhoea in inflammatory bowel disease: authors' reply.
    Aliment Pharmacol Ther. 2011;34:395-6.
    PubMed     Text format     Related articles   
    
    
    
    
37. RAMPTON DS , Shanahan F
    Increased health burden associated with Clostridium difficile diarrhoea in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011;34:394-5.
    PubMed     Text format     Related articles   
    
    
    
    
38. LAHARIE D , Mesli S, El Hajbi F, Chabrun E, et al
    Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.
    Aliment Pharmacol Ther. 2011;34:462-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. VANDE CASTEELE N , Breynaert C, Vermeire S, Rutgeerts PJ, et al
    Incidence of acute severe infusion reactions to infliximab depends on definition used rather than assay.
    Aliment Pharmacol Ther. 2011;34:401-3.
    PubMed     Text format     Related articles   
    
    
    
    
40. MOLNAR T , Farkas K, Nyari T, Nagy F, et al
    Every fourth patient with Crohn's disease has anti-TNF dependency.
    Aliment Pharmacol Ther. 2011;34:400-1.
    PubMed     Text format     Related articles   
    
    
    
    
41. KAMM MA , Hanauer SB, Panaccione R, Colombel JF, et al
    Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.
    Aliment Pharmacol Ther. 2011;34:306-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
42. CHAN SS , Luben R, Bergmann MM, Boeing H, et al
    Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study.
    Aliment Pharmacol Ther. 2011 Jul 26. doi: 10.1111/j.1365-2036.2011.04784.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. RAHIER JF , De Beauce S, Dubuquoy L, Erdual E, et al
    Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 Jul 7. doi: 10.1111/j.1365-2036.2011.04759.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. GONZALEZ-LAMA Y , Bermejo F, Lopez-Sanroman A, Garcia-Sanchez V, et al
    Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.
    Aliment Pharmacol Ther. 2011 Jul 3. doi: 10.1111/j.1365-2036.2011.04756.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. DANESE S , Fiorino G, Reinisch W
    Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-alpha therapy.
    Aliment Pharmacol Ther. 2011;34:1-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. TERRY A , Grogan JL, Casson DH, Dalzell AM, et al
    Tube feeding therapy in paediatric Crohn's disease.
    Aliment Pharmacol Ther. 2011;34:260-1.
    PubMed     Text format     Related articles   
    
    
    
    
47. BAGEACU S , Coatmeur O, Lemaitre JP, Lointier P, et al
    Appendicectomy as a potential therapy for refractory ulcerative proctitis.
    Aliment Pharmacol Ther. 2011;34:257-8.
    PubMed     Text format     Related articles   
    
    
    
    
48. PANES J , Bouzas R, Chaparro M, Garcia-Sanchez V, et al
    Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease.
    Aliment Pharmacol Ther. 2011;34:125-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. LEE TW , Singh R, Fedorak RN
    A one-hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study.
    Aliment Pharmacol Ther. 2011;34:181-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
50. DE PRETER V , Geboes KP, Bulteel V, Vandermeulen G, et al
    Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the beta-oxidation pathway.
    Aliment Pharmacol Ther. 2011 Jun 26. doi: 10.1111/j.1365-2036.2011.04757.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. TORRES J , de Chambrun GP, Itzkowitz S, Sachar DB, et al
    Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 Jun 22. doi: 10.1111/j.1365-2036.2011.04753.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. LICHTENSTEIN GR , Ramsey D, Rubin DT
    Endoscopic mucosal healing in ulcerative colitis: authors' reply.
    Aliment Pharmacol Ther. 2011;33:1255-6.
    PubMed     Text format     Related articles   
    
    
    
    
53. LEVY LC , Siegel CA
    Endoscopic mucosal healing in ulcerative colitis.
    Aliment Pharmacol Ther. 2011;33:1254-5.
    PubMed     Text format     Related articles   
    
    
    
    
54. MOLNAR T , Farkas K, Nagy F, Szepes Z, et al
    Growth retardation in the newborn of ulcerative colitis patients can be the consequence of drug therapy.
    Aliment Pharmacol Ther. 2011;33:1253-4.
    PubMed     Text format     Related articles   
    
    
    
    
55. CHOURAKI V , Turck D, Colombel JF, Gower-Rousseau C, et al
    The changing epidemiology of paediatric inflammatory bowel disease: authors' reply.
    Aliment Pharmacol Ther. 2011;33:1381-2.
    PubMed     Text format     Related articles   
    
    
    
    
56. HENDERSON P , Russell RK, Satsangi J, Wilson DC, et al
    The changing epidemiology of paediatric inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011;33:1380-1.
    PubMed     Text format     Related articles   
    
    
    
    
57. RUBIO A , Pigneur B, Garnier-Lengline H, Talbotec C, et al
    The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding.
    Aliment Pharmacol Ther. 2011;33:1332-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
58. VIENNE A , Simon T, Cosnes J, Baudry C, et al
    Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort.
    Aliment Pharmacol Ther. 2011 May 27. doi: 10.1111/j.1365-2036.2011.04711.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. TRAVIS SP , Higgins PD, Orchard T, Van Der Woude CJ, et al
    Review article: defining remission in ulcerative colitis.
    Aliment Pharmacol Ther. 2011 May 25. doi: 10.1111/j.1365-2036.2011.04701.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. STEENHOLDT C , Svenson M, Bendtzen K, Thomsen OO, et al
    Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 May 3. doi: 10.1111/j.1365-2036.2011.04682.
    PubMed     Text format     Related articles   
    
    
    
    
61. ZELINKOVA Z , de Haar C, de Ridder L, Pierik MJ, et al
    High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy.
    Aliment Pharmacol Ther. 2011;33:1053-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. BEN-HORIN S , Chowers Y
    Review article: loss of response to anti-TNF treatments in Crohn's disease.
    Aliment Pharmacol Ther. 2011;33:987-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. CHOURAKI V , Savoye G, Dauchet L, Vernier-Massouille G, et al
    The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007).
    Aliment Pharmacol Ther. 2011;33:1133-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. FEAGAN BG , Hanauer SB, Coteur G, Schreiber S, et al
    Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.
    Aliment Pharmacol Ther. 2011;33:1143-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
65. VEERAPPAN SG , O'Morain CA, Daly JS, Ryan BM, et al
    Review article: the effects of antitumour necrosis factor-alpha on bone metabolism in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 Apr 26. doi: 10.1111/j.1365-2036.2011.04667.
    PubMed     Text format     Related articles   
    
    
    
    
66. JEN MH , Saxena S, Bottle A, Aylin P, et al
    Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 Apr 24. doi: 10.1111/j.1365-2036.2011.04661.
    PubMed     Text format     Related articles   
    
    
    
    
67. BENTLEY RW , Keown D, Merriman TR, Raj Krishnan M, et al
    Vitamin D receptor gene polymorphism associated with inflammatory bowel disease in New Zealand males.
    Aliment Pharmacol Ther. 2011;33:855-856.
    PubMed     Text format     Related articles   
    
    
    
    
68. NAKASE H , Matsuura M, Uza N, Chiba T, et al
    Tacrolimus suppresses IL-12/IL23 p40 in Crohn's disease and heals fistulae refractory to anti-TNF-alpha therapy.
    Aliment Pharmacol Ther. 2011;33:979-80.
    PubMed     Text format     Related articles   
    
    
    
    
69. SURA R , Colombel JF, Van Kruiningen HJ
    Lymphatics, tertiary lymphoid organs and the granulomas of Crohn's disease: an immunohistochemical study.
    Aliment Pharmacol Ther. 2011;33:930-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. NERICH V , Jantchou P, Boutron-Ruault MC, Monnet E, et al
    Low exposure to sunlight is a risk factor for Crohn's disease.
    Aliment Pharmacol Ther. 2011;33:940-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. DANESE S , Colombel JF, Reinisch W, Rutgeerts PJ, et al
    Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience.
    Aliment Pharmacol Ther. 2011;33:857-69.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
72. ORCHARD TR , van der Geest SA, Travis SP
    Randomised clinical trial: early assessment after 2 weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question.
    Aliment Pharmacol Ther. 2011 Mar 8. doi: 10.1111/j.1365-2036.2011.04620.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. HARRIS MS , Lichtenstein GR
    Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis.
    Aliment Pharmacol Ther. 2011 Mar 8. doi: 10.1111/j.1365-2036.2011.04619.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. GISBERT JP , Chaparro M, Esteve M
    Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011;33:619-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. LICHTENSTEIN GR , Ramsey D, Rubin DT
    Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis.
    Aliment Pharmacol Ther. 2011;33:672-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. PEYRIN-BIROULET L , Oussalah A, Roblin X, Sparrow MP, et al
    The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts.
    Aliment Pharmacol Ther. 2011;33:707-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. LAHARIE D , Reffet A, Belleannee G, Chabrun E, et al
    Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
    Aliment Pharmacol Ther. 2011;33:714-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. FEAGAN BG , Sandborn WJ, Wolf DC, Coteur G, et al
    Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn's disease with prior loss of response to infliximab.
    Aliment Pharmacol Ther. 2011;33:541-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
79. RUSSELL RK , Wilson ML, Loganathan S, Bourke B, et al
    A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 Feb 22. doi: 10.1111/j.1365-2036.2011.04603.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. PEYRIN-BIROULET L , Lemann M
    Review article: remission rates achievable by current therapies for inflammatory bowel disease.
    Aliment Pharmacol Ther. 2011 Feb 15. doi: 10.1111/j.1365-2036.2011.04599.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. HART AL , Ng SC
    Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis? authors' reply.
    Aliment Pharmacol Ther. 2011;33:414-5.
    PubMed     Text format     Related articles   
    
    
    
    
82. NAKASE H , Yamamoto S, Matsuura M, Chiba T, et al
    Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis?
    Aliment Pharmacol Ther. 2011;33:413-4.
    PubMed     Text format     Related articles   
    
    
    
    
83. MOLNAR T , Farkas K, Szepes Z, Nagy F, et al
    Infliximab rescue therapy in steroid-refractory ulcerative colitis: is more really more?
    Aliment Pharmacol Ther. 2011;33:412-3.
    PubMed     Text format     Related articles   
    
    
    
    
84. RAHIER JF , Papay P, Salleron J, Sebastian S, et al
    Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series.
    Aliment Pharmacol Ther. 2011;33:499-500.
    PubMed     Text format     Related articles   
    
    
    
    
85. THANARAJ S , Hamlin PJ, Ford AC
    Potential role of granulocyte/monocyte adsorptive apheresis for ulcerative colitis with concomitant CMV infection: authors' reply.
    Aliment Pharmacol Ther. 2011;33:498.
    PubMed     Text format     Related articles   
    
    
    
    
86. NAKASE H , Matsuura M, Chiba T
    Potential role of granulocyte/monocyte adsorptive apheresis for ulcerative colitis with concomitant CMV infection.
    Aliment Pharmacol Ther. 2011;33:497-8.
    PubMed     Text format     Related articles   
    
    
    
    
87. TURSI A , Elisei W, Giorgetti GM, Aiello F, et al
    Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease.
    Aliment Pharmacol Ther. 2011;33:358-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. KOPYLOV U , Mantzaris GJ, Katsanos KH, Reenaers C, et al
    The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab.
    Aliment Pharmacol Ther. 2011;33:349-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
89. THANARAJ S , Hamlin PJ, Ford AC
    Granulocyte and monocyte adsorptive apheresis in the management of ulcerative colitis: authors' reply.
    Aliment Pharmacol Ther. 2011;33:289.
    PubMed     Text format     Related articles   
    
    
    
    
90. YAMAMOTO T
    Granulocyte and monocyte adsorptive apheresis in the management of ulcerative colitis.
    Aliment Pharmacol Ther. 2011;33:288.
    PubMed     Text format     Related articles   
    
    
    
    
91. SCHREIBER S , Lawrance IC, Thomsen OO, Hanauer SB, et al
    Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study.
    Aliment Pharmacol Ther. 2011;33:185-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. DE BIE CI , Hummel TZ, Kindermann A, Kokke FT, et al
    The duration of effect of infliximab maintenance treatment in paediatric Crohn's disease is limited.
    Aliment Pharmacol Ther. 2011;33:243-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. TOZER PJ , Burling D, Gupta A, Phillips RK, et al
    Review article: medical, surgical and radiological management of perianal Crohn's fistulas.
    Aliment Pharmacol Ther. 2011;33:5-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
94. GOODHAND JR , Alazawi W, Rampton DS
    Systematic review: Clostridium difficile and inflammatory bowel disease.
    Aliment Pharmacol Ther. 2010 Dec 30. doi: 10.1111/j.1365-2036.2010.04548.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. GOODHAND JR , Kamperidis N, Nguyen H, Wahed M, et al
    Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis.
    Aliment Pharmacol Ther. 2010 Dec 29. doi: 10.1111/j.1365-2036.2010.04554.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. NG SC , Chan FK, Sung JJ
    Review article: the role of non-biological drugs in refractory inflammatory bowel disease.
    Aliment Pharmacol Ther. 2010 Dec 8. doi: 10.1111/j.1365-2036.2010.04541.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. RAATIKAINEN K , Mustonen J, Pajala MO, Heikkinen M, et al
    The effects of pre- and post-pregnancy inflammatory bowel disease diagnosis on birth outcomes.
    Aliment Pharmacol Ther. 2010 Dec 8. doi: 10.1111/j.1365-2036.2010.04538.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. KRUIS W , Jonaitis L, Pokrotnieks J, Mikhailova TL, et al
    Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis.
    Aliment Pharmacol Ther. 2010 Dec 8. doi: 10.1111/j.1365-2036.2010.04537.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. TAXONERA C , Estelles J, Fernandez-Blanco I, Merino O, et al
    Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab.
    Aliment Pharmacol Ther. 2010 Dec 7. doi: 10.1111/j.1365-2036.2010.04531.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. SUBRAMANIAN V , Mannath J, Ragunath K, Hawkey CJ, et al
     Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease.
     Aliment Pharmacol Ther. 2010 Dec 5. doi: 10.1111/j.1365-2036.2010.04525.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. THANARAJ S , Hamlin PJ, Ford AC
     Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis.
     Aliment Pharmacol Ther. 2010;32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. BENDIX-STRUVE M , Bartels LE, Agnholt J, Dige A, et al
     Vitamin D3 treatment of Crohn's disease patients increases stimulated T cell IL-6 production and proliferation.
     Aliment Pharmacol Ther. 2010;32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. SPRAKES MB , Ford AC, Suares NC, Warren L, et al
     Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience.
     Aliment Pharmacol Ther. 2010;32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
104. TANG T , Targan SR, Li ZS, Xu C, et al
     Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine.
     Aliment Pharmacol Ther. 2010 Nov 30. doi: 10.1111/j.1365-2036.2010.04515.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. HALPIN SJ , Hamlin PJ, Ford AC
     Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates.
     Aliment Pharmacol Ther. 2010;32:1294-5.
     PubMed     Text format     Related articles   
     
     
     
     
106. SAMUEL S , Loftus EV Jr, Sandborn WJ
     The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosis.
     Aliment Pharmacol Ther. 2010;32:1207-9.
     PubMed     Text format     Related articles   
     
     
     
     
107. LICHTENSTEIN GR , Forbes WP
     Reporting of relapse rates in a trial of mesalazine for ulcerative colitis: authors' reply.
     Aliment Pharmacol Ther. 2010;32:1206-7.
     PubMed     Text format     Related articles   
     
     
     
     
108. FORD AC
     Reporting of relapse rates in a trial of mesalazine for ulcerative colitis.
     Aliment Pharmacol Ther. 2010;32:1205-6.
     PubMed     Text format     Related articles   
     
     
     
     
109. OUSSALAH A , Laurent V, Bruot O, Gueant JL, et al
     Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn's disease.
     Aliment Pharmacol Ther. 2010;32:1135-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. LICHTIGER S , Binion DG, Wolf DC, Present DH, et al
     The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy.
     Aliment Pharmacol Ther. 2010;32:1228-39.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. WAUGH AW , Garg S, Matic K, Gramlich L, et al
     Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort.
     Aliment Pharmacol Ther. 2010;32:1129-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2010
112. STEEL AW , Mela CM, Lindsay JO, Gazzard BG, et al
     Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment.
     Aliment Pharmacol Ther. 2010 Oct 29. doi: 10.1111/j.1365-2036.2010.04499.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. SIEGEL CA
     Review article: explaining risks of inflammatory bowel disease therapy to patients.
     Aliment Pharmacol Ther. 2010 Oct 26. doi: 10.1111/j.1365-2036.2010.04489.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. JELSNESS-JORGENSEN LP , Bernklev T, Henriksen M, Torp R, et al
     Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease.
     Aliment Pharmacol Ther. 2010 Oct 25. doi: 10.1111/j.1365-2036.2010.04498.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. ALOI M , Di Nardo G, Conte F, Mazzeo L, et al
     Methotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centre.
     Aliment Pharmacol Ther. 2010;32:1017-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. PITTET V , Juillerat P, Michetti P, Vader JP, et al
     Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort.
     Aliment Pharmacol Ther. 2010;32:1007-16.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. LICHTENSTEIN GR , Gordon GL, Zakko S, Murthy U, et al
     Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial.
     Aliment Pharmacol Ther. 2010;32:990-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. GUSTAVSSON A , Jarnerot G, Hertervig E, Friis-Liby I, et al
     Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.
     Aliment Pharmacol Ther. 2010;32:984-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. STEED H , Macfarlane GT, Blackett KL, Bahrami B, et al
     Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease.
     Aliment Pharmacol Ther. 2010;32:872-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
120. KANE SV , Robinson A
     Review article: understanding adherence to medication in ulcerative colitis - innovative thinking and evolving concepts.
     Aliment Pharmacol Ther. 2010 Sep 3. doi: 10.1111/j.1365-2036.2010.04445.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
121. GARCIA-BOSCH O , Ricart E, Panes J
     Review article: stem cell therapies for inflammatory bowel disease - efficacy and safety.
     Aliment Pharmacol Ther. 2010 Aug 19. doi: 10.1111/j.1365-2036.2010.04439.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. NAKASE H , Yamamoto S, Matsuura M, Honzawa Y, et al
     Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus.
     Aliment Pharmacol Ther. 2010;32:510-1.
     PubMed     Text format     Related articles   
     
     
     
     July 2010
123. VON DER WEID PY , Rainey KJ
     Review article: lymphatic system and associated adipose tissue in the development of inflammatory bowel disease.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. HART AL , Ng SC
     Review article: the optimal medical management of acute severe ulcerative colitis.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. HERRLINGER KR , Stange EF
     Ulcerative colitis: failed tacrolimus-infliximab or surgery? authors' reply.
     Aliment Pharmacol Ther. 2010;32:309.
     PubMed     Text format     Related articles   
     
     
     
     
126. ORESLAND T
     Ulcerative colitis: failed tacrolimus - infliximab or surgery?
     Aliment Pharmacol Ther. 2010;32:308-9.
     PubMed     Text format     Related articles   
     
     
     
     
127. NIELSEN MJ , Norgaard M, Holland-Fisher P, Christensen LA, et al
     Self-reported antenatal adherence to medical treatment among pregnant women with Crohn's disease.
     Aliment Pharmacol Ther. 2010;32:49-58.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
128. FEAGAN BG , Reilly MC, Gerlier L, Brabant Y, et al
     Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn's disease in the PRECiSE 2 study.
     Aliment Pharmacol Ther. 2010;31:1276-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. PANACCIONE R , Colombel JF, Sandborn WJ, Rutgeerts P, et al
     Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease.
     Aliment Pharmacol Ther. 2010;31:1296-309.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. VAN GEENEN EJ , de Boer NK, Stassen P, Linskens RK, et al
     Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon.
     Aliment Pharmacol Ther. 2010;31:1322-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. BOUGUEN G , Roblin X, Bourreille A, Feier L, et al
     Infliximab for refractory ulcerative proctitis.
     Aliment Pharmacol Ther. 2010;31:1178-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. AMRE DK , Mack DR, Morgan K, Israel D, et al
     Susceptibility loci reported in genome-wide association studies are associated with Crohn's disease in Canadian children.
     Aliment Pharmacol Ther. 2010;31:1186-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
133. GIES N , Kroeker KI, Wong K, Fedorak RN, et al
     Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single center cohort.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. BULTMAN E , Kuipers EJ, van der Woude CJ
     Systematic review: steroid withdrawal in anti-TNF-treated patients with inflammatory bowel disease.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. HARTMANN F , Stein J
     Clinical trial: controlled, open, randomized multicenter study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. VAN LANGENBERG DR , Gibson PR
     Systematic review: fatigue in inflammatory bowel disease.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. MOLNAR T , Farkas K, Nagy F, Szepes Z, et al
     Infliximab safety profile and long-term applicability in inflammatory bowel disease: clinical experiences from the Eastern side of Europe.
     Aliment Pharmacol Ther. 2010;31:1152-3.
     PubMed     Text format     Related articles   
     
     
     
     
138. HERRLINGER KR , Barthel DN, Schmidt KJ, Buning J, et al
     Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus.
     Aliment Pharmacol Ther. 2010;31:1036-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
139. SMITH MA , Irving PM, Marinaki AM, Sanderson JD, et al
     Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. SHEN B , Patel S, Lian L
     Natural history of Crohn's disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis.
     Aliment Pharmacol Ther. 2010;31:745-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. NAKASE H , Honzawa Y, Chiba T
     Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease.
     Aliment Pharmacol Ther. 2010;31:926-7.
     PubMed     Text format     Related articles   
     
     
     
     
142. KARIV R , Plesec TP, Gaffney K, Lian L, et al
     Pyloric gland metaplasia and pouchitis in patients with ileal pouch-anal anastomoses.
     Aliment Pharmacol Ther. 2010;31:862-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. DOHERTY GA , Bennett GC, Cheifetz AS, Moss AC, et al
     Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease.
     Aliment Pharmacol Ther. 2010;31:802-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
144. SONI S , Srirajaskanthan R, Lucas SB, Alexander S, et al
     Lymphogranuloma venereum proctitis masquerading as inflammatory bowel disease in 12 homosexual men.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. SIDHU R , Wilson P, Wright A, Yau CW, et al
     Faecal lactoferrin - a novel test to differentiate between the irritable and inflamed bowel?
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. NICHOLLS RJ , Clark DN, Kelso L, Crowe AM, et al
     Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. DIGNASS AU , Eriksson A, Kilander A, Pukitis A, et al
     Clinical trial: five or ten cycles of granulocyte-monocyte apheresis (GMA) show equivalent efficacy and safety in ulcerative colitis.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. YAMAMOTO S , Nakase H, Chiba T
     Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis: authors' reply.
     Aliment Pharmacol Ther. 2010;31:677-8.
     PubMed     Text format     Related articles   
     
     
     
     
149. ROMANO C , Comito D, Famiani A, Fries W, et al
     Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis.
     Aliment Pharmacol Ther. 2010;31:676-7.
     PubMed     Text format     Related articles   
     
     
     
     
150. VENY M , Esteller M, Ricart E, Pique JM, et al
     Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.
     Aliment Pharmacol Ther. 2010;31:561-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. MUELLER T , Rieder B, Bechtner G, Pfeiffer A, et al
     The response of Crohn's strictures to endoscopic balloon dilation.
     Aliment Pharmacol Ther. 2010;31:634-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
152. LILLESTOL K , Helgeland L, Arslan Lied G, Florvaag E, et al
     Indications of "atopic bowel" in patients with self-reported food hypersensitivity.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. NEWNHAM E , Gearry R, Gibson P
     Factors associated with radiation exposure in patients with inflammatory bowel disease.
     Aliment Pharmacol Ther. 2010;31:534-5.
     PubMed     Text format     Related articles   
     
     
     
     
154. WEDENOJA S , Hoglund P, Holmberg C
     Review article: the clinical management of congenital chloride diarrhoea.
     Aliment Pharmacol Ther. 2010;31:477-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. STAL P , Befrits R, Ronnblom A, Danielsson A, et al
     Clinical trial: the safety and short-term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn's disease.
     Aliment Pharmacol Ther. 2010;31:387-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
156. LYAKHOVICH A , Gasche C
     Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine.
     Aliment Pharmacol Ther. 2010;31:202-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. DOMENECH E , Zabana Y, Garcia-Planella E, Lopez San Roman A, et al
     Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective study before and after infliximab availability.
     Aliment Pharmacol Ther. 2010;31:233-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. SZABO H , Fiorino G, Spinelli A, Rovida S, et al
     Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases.
     Aliment Pharmacol Ther. 2010;31:189-201.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. COHEN RD , Yu AP, Wu EQ, Xie J, et al
     Systematic review: costs of ulcerative colitis in Western countries.
     Aliment Pharmacol Ther. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. ALLEZ M , Vermeire S, Mozziconacci N, Michetti P, et al
     The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies.
     Aliment Pharmacol Ther. 2010;31:92-101.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. GALLAHAN WC , Case D, Bloomfeld RS
     An analysis of the placebo effect in Crohn's disease over time.
     Aliment Pharmacol Ther. 2010;31:102-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2009
162. OUSSALAH A , Roblin X, Laharie D, Filippi J, et al
     Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey.
     Aliment Pharmacol Ther. 2009;30:854-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. BOUGUEN G , Trouilloud I, Siproudhis L, Oussalah A, et al
     Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab.
     Aliment Pharmacol Ther. 2009;30:749-56.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2009
164. ORCHARD TR , Holt H, Bradbury L, Hammersma J, et al
     The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease.
     Aliment Pharmacol Ther. 2009;29:193-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: